Completed OBSERVATIONAL NCT01004809

AVODART® Alopecia Post-marketing Surveillance (PMS) (AVODART®PMS)

An Open Label, Multi-centre, Non-interventional Post-marketing Surveillance to Monitor the Safety and Effectiveness of AVODART® Administered in Korean Androgenetic Alopecia Patients According to the Prescribing Information

Sponsor: GlaxoSmithKline

Conditions Alopecia

Interventions Dutasteride

Updated 8 times since 2017 Last updated: Jun 18, 2018 Started: Apr 29, 2010 Primary completion: Dec 1, 2012 Completion: Dec 21, 2012

This information is for research purposes only and is not medical advice. Consult a healthcare provider before making any medical decision.

A observational or N/A phase clinical study on Alopecia, this trial is completed. The trial is conducted by GlaxoSmithKline and has accumulated 8 data snapshots since 2010. Longitudinal tracking of this trial contributes to a broader understanding of treatment development timelines.

Status Flow

Change History

8 versions recorded

Sep 2025 — Present [monthly]

Completed
Sep 2024 — Sep 2025 [monthly]

Completed
Jul 2024 — Sep 2024 [monthly]

Completed
Jan 2021 — Jul 2024 [monthly]

Completed
Jul 2018 — Jan 2021 [monthly]

Completed

▶ Show 3 earlier versions

Jun 2018 — Jul 2018 [monthly]

Completed
Apr 2018 — Jun 2018 [monthly]

Completed

Phase: NA → None
Jan 2017 — Apr 2018 [monthly]

Completed NA

First recorded

Apr 2010

Trial started

Per CT.gov start date — pre-dates our first snapshot

Eligibility Summary

No eligibility information available.

Contact Information

Sponsor contact:

GlaxoSmithKline

Data source: GlaxoSmithKline

For direct contact, visit the study record on ClinicalTrials.gov .

Study Locations

• Daejeon, South Korea